Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 30 01 2022
revised: 10 06 2022
pubmed: 15 6 2022
medline: 4 2 2023
entrez: 14 6 2022
Statut: ppublish

Résumé

To explore the metabolic characteristics of arthritis and enthesitis using multispectral opto-acoustic tomography (MSOT), a technology using near-infrared multispectral laser to stimulate tissues and detect the emitted acoustic energy, enabling non-invasive quantification of tissue components in vivo based on differential absorbance at multiple wavelengths. We performed a cross-sectional study in patients with RA or PsA and healthy controls (HCs). Participants underwent clinical, ultrasonographic and MSOT examination of MCP and wrist joints as well as the entheses of the common extensor tendon at the lateral humeral epicondyles and of the patellar, quadriceps and Achilles tendon. MSOT-measured haemoglobin (Hb), oxygen saturation, collagen and lipid levels were quantified and scaled mean differences between affected and unaffected joints and entheses were calculated as defined by clinical examination or ultrasonography using linear mixed effects models. We obtained 1535 MSOT and 982 ultrasonography scans from 87 participants (34 PsA, 17 RA, 36 HCs). Entheseal tenderness was not associated with significant metabolic changes, whereas enthesitis-related sonographic changes were associated with increased total Hb, oxygen saturation and collagen content. In contrast, the presence of arthritis-related clinical and sonographic findings showed increased Hb levels, reduced oxygen saturation and reduced collagen content. Synovial hypertrophy was associated with increased lipid content in the joints. MSOT allows determination of distinct metabolic differences between arthritis and enthesitis in a non-invasive setting in humans in vivo.

Identifiants

pubmed: 35699479
pii: 6608103
doi: 10.1093/rheumatology/keac346
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

841-849

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Koray Tascilar (K)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Filippo Fagni (F)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Arnd Kleyer (A)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Sara Bayat (S)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Robert Heidemann (R)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Florian Steiger (F)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Gerhard Krönke (G)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Daniela Bohr (D)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Andreas Ramming (A)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Fabian Hartmann (F)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Daniel Klett (D)

Deutsches Zentrum fuer Immuntherapie.
Department of Internal Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Anna Federle (A)

Deutsches Zentrum fuer Immuntherapie.
Department of Internal Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Adrian P Regensburger (AP)

Deutsches Zentrum fuer Immuntherapie.
Department of Pediatrics and Adolescent Medicine.

Alexandra L Wagner (AL)

Deutsches Zentrum fuer Immuntherapie.
Department of Pediatrics and Adolescent Medicine.

Ferdinand Knieling (F)

Deutsches Zentrum fuer Immuntherapie.
Department of Pediatrics and Adolescent Medicine.

Markus F Neurath (MF)

Deutsches Zentrum fuer Immuntherapie.
Department of Internal Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Georg Schett (G)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Maximilian Waldner (M)

Deutsches Zentrum fuer Immuntherapie.
Department of Internal Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.

David Simon (D)

Department of Internal Medicine 3.
Deutsches Zentrum fuer Immuntherapie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH